• News
Aug 17 2021

Welcome to the 5th Cell & Gene Therapy World Asia 2021

Asia’s cell and gene therapy industry is investing in long-term global opportunities, especially in CAR-T, CAR-NK, Stem cell and iPSC-based cell therapies, CRISPR-based gene therapies, genome-editing technologies and many more.  Likewise, global investors and partners are keen on developing relationships with Asia’s cell and gene therapy...

VIEW MORE
Aug 17 2021

Join the 9th Annual Biologics World Taiwan 2021

VIEW MORE
Aug 11 2021

The Regenerative Medicine in Taiwan

VIEW MORE
Year

Welcome to the 5th Cell & Gene Therapy World Asia 2021

Aug 17, 2021

Asia’s cell and gene therapy industry is investing in long-term global opportunities, especially in CAR-T, CAR-NK, Stem cell and iPSC-based cell therapies, CRISPR-based gene therapies, genome-editing technologies and many more.  Likewise, global investors and partners are keen on...

Join the 9th Annual Biologics World Taiwan 2021

Aug 17, 2021

While China, India, and Korea are leading the pack in the Asia region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector and capture a share of the global market. The 2009 national plan for biotech development helped kick-start the sector,...

The Regenerative Medicine in Taiwan

Aug 11, 2021

The 2021 Taiwan Regenerative Medicine Symposium is held on August 17th, 2021. During the symposium, leaders of regenerative medicine in Taiwan will provide a comprehensive look at the work of regenerative medicine done in Taiwan that offers promise for further local and...